Announcement PDF 23 November 2021 Company Announcements Office ASX Limited Level 6, 20 Bridge Street SYDNEY NSW 2000 CLEANSING NOTICE PURSUANT TO SHARE PURCHASE PLAN Race Oncology Limited (ACN 149 318 749) (ASX:RAC) (Company) gives this notice in accordance with ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547 (Instrument). The Company confirms that it will make offers to issue fully paid ordinary shares (Shares) under a share purchase plan (announced to ASX on 23 November 2021) without disclosure to investors under Part 6D.2 of the Corporations Act 2001 (Cth). In accordance with the Instrument, the Company gives notice that: 1. it will be issuing the Shares without disclosure to investors under Part 6D.2 or Part 7.9 of the Corporations Act 2001 (Cth); 2. this notice is being given in accordance with ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547; 3. as at the date of this notice, the Company has complied with: (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and (ii) section 674 of the Corporations Act; and 4. as at the date of this notice, there is no information that is “excluded information” (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company. The release of this announcement was authorised by the Board of Race Oncology Limited. For and on behalf of Race Oncology Limited Peter Webse Company Secretary Race Oncology Ltd ABN 61 149 318 749 Registered office: L36, 1 Macquarie Place, Sydney NSW 2000 www.raceoncology.com